• Ticker

    Advertisement
DJIA 12,890.46 6.51 0.05%
NASDAQ 2,927.23 11.37 0.39%
S&P 500 1,351.95 1.99 0.15%
Maintenance Notification

Quotes and Portfolios will be down on Sunday February 12, 2012 from 2 AM to 4 AM while we perform maintenance on the site. We apologize for the inconvenience.

$0.16 $0.00 (0.00%)

Quote as of 3:14 PM EST on 02/08/12

AVITA MEDICAL LTD ORD

NASDAQOTH:AVMXF.PK

Jump to this page for:

Related Resources

Avita Medical Acquires Intellectual Property from McComb Foundation, Including Core IP Related to ReCell® Spray-On Skin™

11/28/2011 by Business Wire

Avita Medical Launches ReCell Spray-On-Skin Treatment of Venous Ulcers

10/14/2011 by Genetic Engineering News

Avita Medical Launches ReCell® Spray-On-Skin™ Treatment of Venous Ulcers

10/14/2011 by Business Wire

Avita Medical Enters into Joint Venture to Expand Sales of ReCell® Spray-On Skin™ Throughout the Middle East and North Africa

9/7/2011 by PharmiWeb.com - UK

Avita Medical Enters into Joint Venture to Expand Sales of ReCell® Spray-On Skin™ Throughout the Middle East and North Africa

9/7/2011 by Business Wire

Avita Medical Appoints Senior Researcher Dr. Michael Mendicino to Lead and Expand Its Regenerative Medicine R&D Program

8/27/2011 by PharmiWeb.com - UK

Avita Medical Appoints Senior Researcher Dr. Michael Mendicino to Lead and Expand Its Regenerative Medicine R&D Program

8/26/2011 by Genetic Engineering News

Avita Medical Appoints Senior Researcher Dr. Michael Mendicino to Lead and Expand Its Regenerative Medicine R&D Program

8/26/2011 by Business Wire

Avita Medical Receives FDA Approval to Initiate Study of Its ReCell® Spray-On-Skin™ for Cosmetic Indications

8/25/2011 by PharmiWeb.com - UK

Avita Medical Receives FDA Approval to Initiate Study of Its ReCell® Spray-On-Skin™ for Cosmetic Indications

8/25/2011 by Business Wire

Wilson HTM Initiates Coverage of Avita Medical

7/29/2011 by PharmiWeb.com - UK

Wilson HTM Initiates Coverage of Avita Medical

7/28/2011 by Genetic Engineering News

Avita Medical Closes Equity Raising AUD$9m

6/24/2011 by Genetic Engineering News

Avita Medical Reports Additional Market Acceptance of its ReCell® Spray-On-Skin™

6/10/2011 by PharmiWeb.com - UK

Avita Medical Begins Commercialization of ReCell® Spray-on-Skin™ in Six Countries in the Arabian Peninsula

5/26/2011 by PharmiWeb.com - UK

Avita Medical Reports Third Quarter- and Nine-Month Financial Results

5/4/2011 by PharmiWeb.com - UK

Avita Medical Reports Third Quarter- and Nine-Month Financial Results

5/3/2011 by Genetic Engineering News

Study Demonstrates That Avita Medical’s ReCell® Spray-On Skin™ in Combination with a Biological Wound Dressing Has “a Number of Benefits Compared to Standard Skin-Grafting Techniques”

4/28/2011 by PharmiWeb.com - UK

Study Demonstrates That Avita Medical's ReCell® Spray-On SkinT "Has Potentially Broad Application To The Healing Of Acute And Chronic Wounds"

4/25/2011 by Biocompare

Study Demonstrates That Avita Medical’s ReCell® Spray-On Skin™ “Has Potentially Broad Application to the Healing of Acute and Chronic Wounds”

4/21/2011 by PharmiWeb.com - UK

Avita Medical Expands Sales and Marketing Operations in Europe

4/19/2011 by PharmiWeb.com - UK

Australian Market Report of May 31, 2010: Avita Medical (ASX:AVH) Advances Marketing in China and Taiwan

5/30/2010 by StockWatch